| 2024-03-12 | Sale | AdaptHealth Corp. AHCO | *Possible Member of 10% Group | 114,906 0.0832% | $10.70 | $1.23M | -6.83% | |
| 2024-03-11 | Sale | AdaptHealth Corp. AHCO | *Possible Member of 10% Group | 182,607 0.1361% | $11.02 | $2.01M | -6.82% | |
| 2024-03-08 | Sale | AdaptHealth Corp. AHCO | *Possible Member of 10% Group | 52,487 0.0387% | $10.93 | $573,652 | -6.68% | |
| 2024-02-16 | Larimar Therapeutics, Inc. LRMR | * Director by Deputization | 4.29M 6.6831% | $8.74 | $37.5M | -38.46% | ||
| 2022-11-03 | Nuvalent, Inc. NUVL | director | 650,000 1.388% | $33.50 | $21.77M | +32.21% | ||
| 2022-11-03 | Nuvalent, Inc. NUVL | director | 1.3M 2.776% | $33.50 | $43.55M | +32.21% | ||
| 2022-09-16 | Larimar Therapeutics, Inc. LRMR | 11.11M 49.2054% | $3.15 | $35M | +21.88% | |||
| 2021-10-26 | Xilio Therapeutics, Inc. XLO | 10 percent owner | 387,500 1.4134% | $16.00 | $6.2M | -76.08% | ||
| 2021-08-02 | Nuvalent, Inc. NUVL | 600,000 0.7259% | $8.50 | $5.1M | -23.21% | |||
| 2021-07-09 | Sale | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 198,650 0.6325% | $15.81 | $3.14M | +11.25% | |
| 2021-07-07 | Sale | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 13,674 0.045% | $15.87 | $216,993 | +14.33% | |
| 2021-07-06 | Sale | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 98,478 0.322% | $16.20 | $1.59M | +11.07% | |
| 2021-07-02 | Sale | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 21,198 0.0709% | $17.01 | $360,599 | +7.82% | |
| 2021-06-30 | Larimar Therapeutics, Inc. LRMR | 685,710 3.341% | $8.75 | $6M | -2.39% | |||
| 2021-06-01 | Singular Genomics Systems, Inc. OMIC | 10 percent owner | 1.5M 3.3473% | $22.00 | $33M | -62.91% | ||
| 2021-05-04 | Werewolf Therapeutics, Inc. HOWL | 10 percent owner | 800,000 4.4986% | $16.00 | $12.8M | -12.48% | ||
| 2021-03-30 | Edgewise Therapeutics, Inc. EWTX | 10 percent owner | 1.25M 1.3005% | $16.00 | $20M | -42.5% | ||
| 2021-02-09 | Terns Pharmaceuticals, Inc. TERN | 10 percent owner | 665,000 3.5834% | $17.00 | $11.3M | -48.44% | ||
| 2021-01-08 | Sale | Lumos Pharma, Inc. LUMO | 10 percent owner | 106,512 1.2892% | $22.31 | $2.38M | -53.79% | |
| 2021-01-07 | Sale | Lumos Pharma, Inc. LUMO | 10 percent owner | 16,172 0.2017% | $24.54 | $396,821 | -56.72% |